Cathay Biotech Inc.
SHH: 688065.SS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shanghai Stock Exchange
- Sector
- Basic Materials
- Industry
- Chemicals
- CEO
- Xiucai Liu
- Employees
- 1,735
- Headquarters
- Shanghai, China
- IPO year
- 2020
- Market cap
- CN¥34.3B
- Website
- https://www.cathaybiotech.com
Loading 688065…
Loading profile data…Frequently asked questions about 688065
What does Cathay Biotech Inc. (688065.SS) do?
Cathay Biotech Inc. engages in the production and sale of bio-based polyamide, bio-based DN5, long chain dibasic acids, and biobutanol. The company is headquartered in Shanghai, China.
Where does 688065.SS trade?
Cathay Biotech Inc. (688065.SS) trades on the Shanghai Stock Exchange.
What sector is 688065.SS in?
Cathay Biotech Inc. (688065.SS) operates in the Basic Materials sector, specifically in the Chemicals industry.
Who is the CEO of Cathay Biotech Inc.?
Xiucai Liu is the chief executive officer of Cathay Biotech Inc. (688065.SS).
Where is Cathay Biotech Inc. headquartered?
Cathay Biotech Inc. is headquartered in China.
Does 688065.SS pay a dividend?
Yes — Cathay Biotech Inc. (688065.SS) paid a trailing twelve-month dividend of CNY 0.40 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 688065.SS go public?
Cathay Biotech Inc. (688065.SS) completed its initial public offering in 2020.